#Oxurion #receives #transparency #notification #Fidelity
Leuven, BELGIUM, Boston, MA, USA – November 4th 2022– 7 p.m. CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next-generation standard ophthalmic therapies with clinical utility in retinal vascular diseases, announced today that it complies with Belgian transparency laws.1has received a transparency notice following the issuance of new shares as part of the capital commitment entered into with Negma Group.
Oxurion has received a transparency notice from Fidelity Management & Research Company LLC stating that a passive breach below a threshold has caused its 3,128,819 common shares to fall below the 5% threshold.
Content of Fidelity notification
reason of notification
Passive crossing of a threshold
notifications from
A parent company or controlling person
Threshold exceeded
5%
denominator
66,675,765
Read on GNW: Oxurion receives transparency notification from Fidelity
